Tag: XenoPort

Sentiments dictate Xenoport and General Electric

XNPT –  XenoPort, Inc is a biopharmaceutical company, focused on development and commercialization of drugs for the treatment of neurological and other disorders.

XNPT – Xenoport, Inc

Fundamentals Previously closed at 4.40
Day’s high 4.51
Day’s low 4.33
P/E ratio NA
EPS -1.21


Analysts opinion An Atlanta based private company, Arbor Pharmaceuticals has agreed to acquire XenoPort. Under the terms of agreement, XenoPort stockholders will receive $7.03 per share in cash. Johnson & Weaver, a nationally recognized attorney at law, has launched an investigation on whether the proposed deal price is adequate. Analyst confidence meter, a proprietary algorithm of Stockal gives a 70% buy based on analyst ratings.
Sentiments XNPT rose 58% during pre-market today. The sentiment index is 50% positive according to Stockal proprietary algorithm.
Social Media Pulse The stock has 100% higher social media chatter than usual.

Continue Reading…